Noninvasive Antenatal Screening for Fetal RhD in RhD-Negative Women to Guide Targeted Anti-D Prophylaxis
- 21 July 2023
- book chapter
- Published by Springer Nature
- p. 277-289
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHDPLOS ONE, 2013
- Targeted Routine Antenatal Anti-D Prophylaxis in the Prevention of RhD Immunisation - Outcome of a New Antenatal Screening and Prevention ProgramPLOS ONE, 2013
- Clinical application of midtrimester non‐invasive fetal RHD genotyping and identification of RHD variants in a mixed‐ethnic populationPrenatal Diagnosis, 2012
- Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groupsTransfusion, 2012
- Routine Antenatal Anti-D Prophylaxis in Women Who Are Rh(D) Negative: Meta-Analyses Adjusted for Differences in Study Design and QualityPLOS ONE, 2012
- Cell‐free fetal DNA in specimen from pregnant women is stable up to 5 daysPrenatal Diagnosis, 2011
- Fetal RHD genotype detection from circulating cell‐free fetal DNA in maternal plasma in non‐sensitized RhD negative womenPrenatal Diagnosis, 2011
- The relationship between blood groups and diseaseBlood, 2010
- Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility studyBMJ, 2008
- Noninvasive fetal RHD genotyping from maternal plasmaTransfusion Clinique et Biologique, 2007